Overview

Preterm Birth Prevention and Management Market is predicted to value over USD xx billion by 2027 end with a CAGR of over xx% during the forecast period 2020 to 2027.

The rising necessity of preventing preterm births and increased emphasis on targeted therapies and care standards are some of the key factors contributing to the market growth. According to the data provided by the WHO, every year, over 15 million births are preterm. Complications arising from preterm births is the primary cause of mortality in children under the age of 5 with over 1 million deaths recorded in 2015. Over 70% of these deaths are preventable with cost-effective interventions. Due to these factors, it is estimated that the market shall propel during the forecast period.    
Treating progesterone during the pregnancy process shall help many women to be prevented from premature birth and a 17P shot is very effective in such cases. Vaginal progesterone and progesterone shots are two types of progesterone treatments. Vaginal progesterone helps in reducing premature birth in case the women is carrying one baby and has a shorter cervix. The progesterone shots help in reducing the risk of premature birth if the women previously had a premature birth. Such factors shall boost the preterm birth prevention and management market growth.

Preterm Birth Prevention and Management Market

Market Segmentation:

By Therapy Type
•    Progesterone Therapy
•    Corticosteroid Therapy
•    Tocolytics Therapy
•    Antibiotics Therapy 
•    Heparin Profylaxis Therapy
•    Others    
By Route of Administration
•    Oral 
•    Parenteral
•    Vaginal
By Distribution Channel
•    Drug Stores
•    Hospital Pharmacies
•    Mail Order Pharmacies
•    E-Pharmacies
•    Retail Pharmacies
•    Others      
By Region
•    North America
•    Europe
•    Asia-Pacific
•    Latin America
•    Middle East and Africa

The market is fragmented into therapy type, route of administration, distribution channel and region. The therapy type segment is categorised into progesterone therapy, tocolytics therapy, corticosteroid therapy, antibiotics therapy, heparin profylaxis therapy and others. The route of administration segment is diversified into oral, vaginal and parenteral. The oral route is predicted to hold the largest preterm birth prevention and management market share during the forecast period. The distribution channel segment is bifurcated into hospital pharmacies, online pharmacies, drug stores. 

Regional Analysis:

The North America region is predicted to lead the market during the forecast period owing to increased birth rates, rising awareness amongst women regarding preterm birth and major market players have their headquarters in the region. As per the Centers for Disease Control and Prevention, over 1 in every 10 infants were born premature in the US in the year 2018. Such statistics shall provide a boost to the market growth in the region.

Competitive Landscape:                              

The key players associated are AbbVie Inc., Allergan, AMAG Pharmaceuticals, Bayer AG, Ferring B.V., Merck & Co. Inc., Mylan N.V., Pfizer Inc., Teva Pharmaceutical Industries Ltd.

FutureWise Key Takeaways:

•    Growth prospects
•    SWOT analysis 
•    Key market trends 
•    Key data-points affecting market growth

Objectives of the Study:

•    To provide with an exhaustive analysis on the global the preterm birth prevention and management market by therapy type, by route of administration, by distribution channel and by region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
•    To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions 

Flexible Delivery Model:

•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

$3450

Need Assistance

--------

UK : +44 141 628 9353
US : +1 347 709 4931

OR

Contact Sales

What you get


  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included


  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics